Effect of C-Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes

Figure 1

Change in peak sensory nerve conduction velocity in the sural nerves following 3–6 months of C-peptide replacement treatment (red bar) or placebo (gray bar) to patients with type 1 diabetes. The figure presents pooled data from [19, 20].